Literature DB >> 31806872

Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial.

Andishe Attarbaschi1, Georg Mann2, Martin Zimmermann3, Valentino Conter4, Martin Schrappe5, Peter Bader6, Elena Barisone7, Giuseppe Basso8, Andrea Biondi4, Gunnar Cario5, Gianni Cazzaniga4, Antonella Colombini4, Christian Flotho9, Michaela Kuhlen10, Peter Lang11, Melchior Lauten12, Christin Linderkamp3, Franco Locatelli13,14, Luca Lo Nigro15, Anja Möricke5, Felix Niggli16, Renate Panzer-Grümayer2, Rosanna Parasole17, Christina Peters2, Maria Caterina Putti18, Carmelo Rizzari4, Meinolf Suttorp19, Maria Grazia Valsecchi20.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31806872     DOI: 10.1038/s41375-019-0670-y

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  1 in total

Review 1.  [Prognosis of acute lymphoblastic leukemia in children. Results of the French protocol FRALLE 93].

Authors:  G Schaison; M F Auclerc; A Baruchel; T Leblanc; G Leverger
Journal:  Bull Acad Natl Med       Date:  2001       Impact factor: 0.144

  1 in total
  7 in total

1.  One-point flow cytometric MRD measurement to identify children with excellent outcome after intermediate-risk BCP-ALL: results of the ALL-MB 2008 study.

Authors:  Alexander Popov; Guenter Henze; Julia Roumiantseva; Oleg Budanov; Mikhail Belevtsev; Tatiana Verzhbitskaya; Elena Boyakova; Liudmila Movchan; Grigory Tsaur; Maria Fadeeva; Svetlana Lagoyko; Liudmila Zharikova; Natalia Miakova; Dmitry Litvinov; Olga Khlebnikova; Olga Streneva; Elena Stolyarova; Natalia Ponomareva; Galina Novichkova; Larisa Fechina; Olga Aleinikova; Alexander Karachunskiy
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-28       Impact factor: 4.322

2.  Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL - long-term follow-up from the prospective ALL-SCT 2003 trial.

Authors:  Christina Peters; Michael H Albert; Anna Eichinger; Ulrike Poetschger; Evgenia Glogova; Peter Bader; Oliver Basu; Rita Beier; Birgit Burkhardt; Carl-Friedrich Classen; Alexander Claviez; Selim Corbacioglu; Hedwig E Deubzer; Johann Greil; Bernd Gruhn; Tayfun Güngör; Kinan Kafa; Jörn-Sven Kühl; Peter Lang; Bjoern Soenke Lange; Roland Meisel; Ingo Müller; Martin G Sauer; Paul-Gerhardt Schlegel; Ansgar Schulz; Daniel Stachel; Brigitte Strahm; Angela Wawer
Journal:  Leukemia       Date:  2022-09-12       Impact factor: 12.883

3.  Relapsed acute lymphoblastic leukaemia after allogeneic stem cell transplantation: a therapeutic dilemma challenging the armamentarium of immunotherapies currently available (case reports).

Authors:  Fiona Poyer; Anna Füreder; Wolfgang Holter; Christina Peters; Heidrun Boztug; Michael Dworzak; Gernot Engstler; Waltraud Friesenbichler; Stefan Köhrer; Roswitha Lüftinger; Leila Ronceray; Volker Witt; Herbert Pichler; Andishe Attarbaschi
Journal:  Ther Adv Hematol       Date:  2022-05-23

4.  Persistence of Chemotherapy-Induced Peripheral Neuropathy Despite Vincristine Reduction in Childhood B-Acute Lymphoblastic Leukemia.

Authors:  Rozalyn L Rodwin; John A Kairalla; Emily Hibbitts; Meenakshi Devidas; Moira K Whitley; Caroline E Mohrmann; Reuven J Schore; Elizabeth Raetz; Naomi J Winick; Stephen P Hunger; Mignon L Loh; Marilyn J Hockenberry; Anne L Angiolillo; Kirsten K Ness; Nina S Kadan-Lottick
Journal:  J Natl Cancer Inst       Date:  2022-08-08       Impact factor: 11.816

5.  Differing Outcomes of Patients with High Hyperdiploidy and ETV6-RUNX1 Rearrangement in Korean Pediatric Precursor B Cell Acute Lymphoblastic Leukemia.

Authors:  Jae Wook Lee; Seongkoo Kim; Pil-Sang Jang; Nack-Gyun Chung; Bin Cho
Journal:  Cancer Res Treat       Date:  2020-10-08       Impact factor: 4.679

Review 6.  Allogeneic Hematopoietic Stem Cell Transplantation for Children With Acute Lymphoblastic Leukemia: Shifting Indications in the Era of Immunotherapy.

Authors:  Tony H Truong; Cristian Jinca; Georg Mann; Smaranda Arghirescu; Jochen Buechner; Pietro Merli; James A Whitlock
Journal:  Front Pediatr       Date:  2021-12-23       Impact factor: 3.418

7.  Late isolated central nervous system relapse in childhood B-cell acute lymphoblastic leukemia treated with intensified systemic therapy and delayed reduced dose cranial radiation: A report from the Children's Oncology Group study AALL02P2.

Authors:  Caroline Hastings; Yichen Chen; Meenakshi Devidas; A Kim Ritchey; Naomi J Winick; William L Carroll; Stephen P Hunger; Brent L Wood; Robert B Marcus; Julio C Barredo
Journal:  Pediatr Blood Cancer       Date:  2021-07-24       Impact factor: 3.838

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.